SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Somatogen (SMTG)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bharat H. Barai who wrote (401)2/24/1998 10:05:00 AM
From: CarlPerf   of 442
 
Merger annoucement,

Strategically, this is a golden investment opportunity for Baxter. They are acquiring a biotech firm with tremendous potential. Unfortunately, I believe the stock is worth twice what Baxter is offering. Knowing Baxter's negotiating prowess, I believe this represents a "done deal" and other offers will not be forthcoming. Personally, I would not hold Baxter shares and will tender my small holdings in Somatogen.
It is a true irony of life - on the day I join this thread to interact with Somatogen believers, they release an acqusition announcement. Such is life in this topsy/turvy investment world. Good fortunes to all SMTG shareholders.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News